← Every applicant
Nexus FDA Approvals
12 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TACROLIMUSNew drugFeb 12, 2025INJECTABLE, INJECTION |
| METHYLENE BLUENew drugNov 21, 2024SOLUTION, INTRAVENOUS |
| CYCLOPHOSPHAMIDENew drugOct 29, 2024SOLUTION, INTRAVENOUS |
| TRANEXAMIC ACIDNew drugApr 16, 2024SOLUTION, INTRAVENOUS |
| FLUORESCEIN SODIUMNew drugSep 25, 2023INJECTABLE, INTRAVENOUS |
| SODIUM CHLORIDE 0.9%New drugAug 23, 2023SOLUTION, INJECTION |
| POTASSIUM CHLORIDENew drugAug 14, 2023INJECTABLE, INJECTION |
| STERILE WATER FOR INJECTIONNew drugJul 11, 2023LIQUID, N/A |
| NELARABINENew drugJun 2, 2023INJECTABLE, INTRAVENOUS |
| TIROFIBAN HYDROCHLORIDENew drugFeb 7, 2023SOLUTION, INTRAVENOUS |
| ERYTHROMYCIN LACTOBIONATENew drugFeb 14, 2022INJECTABLE, INJECTION |
| POTASSIUM CHLORIDE 20MEQNew drugMar 18, 2021INJECTABLE, INJECTION |